Category Archives: Samumed

Brief Items of Interest, April 2017

Hair loss news first:

— A great story on Dr. Rox Anderson that was also retweeted by PureTech CEO Daphne Zohar:

In the article, Mr. Anderson is praised by the famous hair loss researcher Dr. George Cotsarelis as being a modern day Dr. Benjamin Franklin. Several people that I highly respect have in the past recommended my reading Dr. Franklin’s autobiography, but the one time I tried, I fell asleep very soon after commencing. If I recall correctly, the English was a bit antiquated and difficult to comprehend in my edition.

— Of the numerous companies working on hair growth related products around the world, US based Samumed has been by far and away the best at getting coverage in major print and online publications. This month, they appeared in Business Insider. Dr. Osman Kibar, the CEO of Samumed, is a great poker player. I hope that he is not bluffing the world in real life too. Key quote:

The $12 billion valuation Samumed has right now is based on the $300 million it has raised over the years. The valuation grew based on its lead compound, with the rest of the pipeline thrown in as a “freebie,” Kibar said.

The Business Insider article became a very popular discussion topic on reddit with some interesting comments. Samumed also appeared in Forbes magazine yet again at the beginning of this month.

— Every 6 months or so, the highly unusual case study known as Mr. “Peter Renardo” posts updates in the comments in here. I still insist never ever even considering such an extreme artery ligature procedure, but do make sure to read Peter’s comments.

Topical Dutasteride would be something that I would seriously consider (h/t commentator “Hairplz”).

— Most people’s favorite hair loss researcher Dr. Takashi Tsuji recently came out with a new study/paper titled “Functional Hair Follicle Regeneration by the Rearrangement of Stem Cells”. However, it is in mice and perhaps not especially groundbreaking (see the 5 or so comments in here after “Paul Phoenix” ‘s comment with the study link in there from April 1 at 12:36 pm — you might see a different time in there depending on your location).

— As if it were not enough that hair loss is connected to higher rates of heart disease (“bing” it), it seems like grey hair might also be linked to higher rates of heart disease. Quote: “Atherosclerosis and hair greying occur through similar biological pathways”.

— When I read this article a week ago, I was certain that it was an exaggeration or a translation error. I contacted HairClone CEO Dr. Paul Kemp and he said that the company’s plans remain the same as outlined in his earlier comments on this blog from a few months ago. In any case, if you have any questions about HairClone, you can ask in the comments to this post and Dr. Kemp will come by and respond when he has some free time. Alternatively, you can ask in this thread on hairsite. And no, hair cloning is definitely not yet here in spite of flashy article titles.

Jason McAteer hair transplant.

And now on to medical items of interest:

— I covered the much hyped skin gun and its inventor Dr. Jörg Gerlach on this blog before (see 2011 video here). I was glad to read a new article on this as I thought that RenovaCare might have given up on this technology.

www.AcneCure2020.com anyone?

— Japan is becoming renowned for medical research, not surprising considering its aging population. A Japanese man recently became the first to receive “reprogrammed” stem cells from another person.

— After reading this post (and a few others on this blog), you might think that I am a very biased Japanophile. However, this is not true…and I had to insert that disclaimer before I included the following Japan focused thought here:

For many years, I have noticed that each time the oldest person in the world died, virtually half the time it was a Japanese person. Of course since birth certificates were nonexistent in most developing countries 100 plus years ago, these statistics are biased towards people from developed countries. Nevertheless, after the oldest person (who I covered on this blog in the past) in the world died yesterday, I went to the the wikipedia list of supercentenarians, and lo an behold, 5 of the oldest 10 people in the world at the moment are Japanese.

Interesting article on extending lifespan.

Update on developing pig organs for human transplants.

Half man, half machine.

— US and Chinese teams collaborate and expand stem cell abilities.

CRISPR gene editing to supercharge agriculture.

Samumed E-mail

Someone associated with Samumed just e-mailed me today (see blue text below for contents) and I was pleasantly surprised since I have not contacted the company anytime recently. The e-mail pertains to their SM04554 topical product to treat male pattern hair loss. Please list your questions for Dr. Yusuf Yazici in the comments, but do not be disappointed if he never responds. Even though they have offered us the opportunity per the last sentence of the below e-mail, I have doubts that I will get any response. Any profanity or sarcasm laced comments will be deleted and/or ignored.

E-mail:

Subject: Samumed presented data on increases in hair follicles observed in its Phase 2 biopsy study for a potential treatment of androgenetic alopecia (AGA) at annual meeting of the American Academy of Dermatology (AAD)

Hi,

I wanted to share a brief update about Samumed, which presented the results to its phase 2 biopsy study on a potential treatment for androgenetic alopecia at the annual meeting of the American Academy of Dermatology.

Specifically, the study revealed three compelling findings:

  • There were statistically significantly higher total follicle counts compared to the vehicle.
  • Samumed’s treatment may be the first leading to follicular neogenesis.
  • There were no serious adverse events reported.

The full release can be viewed on Samumed’s website HERE and I’ve also copied the text below.

Please let me know if you’d like to speak with Samumed’s Chief Medical Officer, Yusuf Yazici, and I’d be happy to connect you.

Best,

Mr. XYZ